Combination Targeted Pulmonary Hypertension Therapy in the Resolution of Dasatinib-Associated Pulmonary Arterial Hypertension

Pulmonary Circulation - United States
doi 10.1177/2045893217716659
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Dasatinib-Induced Pulmonary Arterial Hypertension Treated With Upfront Combination Therapy

Case Reports in Cardiology
Cardiovascular MedicineCardiology
2018English

Combination Therapies in Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2008English

Other Causes of Pulmonary Arterial Hypertension: Pulmonary Veno-Occlusive Disease, Pulmonary Capillary Hemangiomatosis, Porto-Pulmonary Hypertension, HIV- Associated Pulmonary Arterial Hypertension

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2010English

Ambrisentan and Tadalafil Up-Front Combination Therapy in Scleroderma-Associated Pulmonary Arterial Hypertension

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2015English

Combination Therapy in Pulmonary Artery Hypertension

Advances in Pulmonary Hypertension
2008English

Tadalafil Therapy for Pulmonary Arterial Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

Pulmonary Arterial Hypertension

Current Problems in Cardiology
MedicineCardiovascular MedicineCardiology
2011English

Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2013English

Pulmonary Arterial Hypertension Associated With Scleroderma

Advances in Pulmonary Hypertension
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy